54 related articles for article (PubMed ID: 16508570)
1. Candidate genes for the hereditary component of cardiac hypertrophy.
van den Hoff MJ; Postma AV; Michel MC
J Hypertens; 2006 Feb; 24(2):273-7. PubMed ID: 16508570
[No Abstract] [Full Text] [Related]
2. Genetic causation: the end of parsimony?
Padmanabhan S
J Hypertens; 2009 Aug; 27(8):1521-3. PubMed ID: 19622924
[No Abstract] [Full Text] [Related]
3. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
[TBL] [Abstract][Full Text] [Related]
4. Genetic influences of beta-adrenoceptor polymorphisms on arterial functional changes and cardiac remodeling in hypertensive patients.
Yuan M; Ohishi M; Ito N; Sugimoto K; Takagi T; Terai M; Katsuya T; Rakugi H; Wu Z; Ogihara T
Hypertens Res; 2006 Nov; 29(11):875-81. PubMed ID: 17345787
[TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
6. Evolving concepts of left ventricular hypertrophy.
Tikhonoff V; Casiglia E
Eur Heart J; 2008 Apr; 29(7):846-8. PubMed ID: 18337237
[No Abstract] [Full Text] [Related]
7. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gene expression profiling in pressure and volume overload-induced myocardial hypertrophies in rats.
Miyazaki H; Oka N; Koga A; Ohmura H; Ueda T; Imaizumi T
Hypertens Res; 2006 Dec; 29(12):1029-45. PubMed ID: 17378376
[TBL] [Abstract][Full Text] [Related]
9. AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol.
Zarrinpashneh E; Beauloye C; Ginion A; Pouleur AC; Havaux X; Hue L; Viollet B; Vanoverschelde JL; Bertrand L
Biochem Biophys Res Commun; 2008 Nov; 376(4):677-81. PubMed ID: 18812163
[TBL] [Abstract][Full Text] [Related]
10. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.
Maron BJ; Haas TS; Lesser JR
Circulation; 2007 Jun; 115(24):e627-8. PubMed ID: 17576874
[No Abstract] [Full Text] [Related]
11. Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy.
Castro MG; Rodríguez-Pascual F; Magán-Marchal N; Reguero JR; Alonso-Montes C; Morís C; Alvarez V; Lamas S; Coto E
Ann Hum Genet; 2007 Sep; 71(Pt 5):601-10. PubMed ID: 17335511
[TBL] [Abstract][Full Text] [Related]
12. Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis?
Orlowska-Baranowska E; Placha G; Baranowski R; Michalek P; Gora J; Gaciong Z; Stepinska J
J Heart Valve Dis; 2007 Sep; 16(5):495-503. PubMed ID: 17944121
[TBL] [Abstract][Full Text] [Related]
13. Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.
Fu C; Wang H; Wang S; Shi Y; Zhou X; Sun K; Chen J; Song X; Xue H; Hui R
Clin Biochem; 2008 Jul; 41(10-11):773-8. PubMed ID: 18298953
[TBL] [Abstract][Full Text] [Related]
14. [Effects of phlegm-dispelling and blood stasis-resolving traditional Chinese drugs on the blood pressure and cell cycle of left ventricular cardiac myocytes in hypertensive rats].
Chen RQ; Xiong P; Zhou XX; Liang ZQ; Wu LZ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1806-9. PubMed ID: 18971178
[TBL] [Abstract][Full Text] [Related]
15. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
Alves GB; Oliveira EM; Alves CR; Rached HR; Mota GF; Pereira AC; Rondon MU; Hashimoto NY; Azevedo LF; Krieger JE; Negrão CE
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):487-92. PubMed ID: 19404196
[TBL] [Abstract][Full Text] [Related]
16. Myocardin gene regulatory variants as surrogate markers of cardiac hypertrophy - study in a genetically homogeneous population.
Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
Clin Genet; 2008 Jan; 73(1):71-8. PubMed ID: 18028454
[TBL] [Abstract][Full Text] [Related]
17. Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.
Perlini S
J Hypertens; 2007 Jul; 25(7):1341-2. PubMed ID: 17563551
[No Abstract] [Full Text] [Related]
18. Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension.
Dwyer JP; Ritchie ME; Smyth GK; Harrap SB; Delbridge L; Domenighetti AA; Di Nicolantonio R
Hypertens Res; 2008 May; 31(5):941-55. PubMed ID: 18712050
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy.
Cingolani E; Ramirez Correa GA; Kizana E; Murata M; Cho HC; Marbán E
Circ Res; 2007 Jul; 101(2):166-75. PubMed ID: 17556655
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional alterations in the left ventricle of three hypertensive rat models.
Cerutti C; Kurdi M; Bricca G; Hodroj W; Paultre C; Randon J; Gustin MP
Physiol Genomics; 2006 Nov; 27(3):295-308. PubMed ID: 16882881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
